116 related articles for article (PubMed ID: 8524962)
1. Mechanisms to induce tolerance by synthetic monosaccharide lipid A analogues against LPS lethality in mice.
Matsuura M; Nakano M
Prog Clin Biol Res; 1995; 392():539-48. PubMed ID: 8524962
[No Abstract] [Full Text] [Related]
2. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
Matsuura M; Kiso M; Hasegawa A; Nakano M
Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
[TBL] [Abstract][Full Text] [Related]
3. Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.
Perera PY; Manthey CL; Stütz PL; Hildebrandt J; Vogel SN
Infect Immun; 1993 May; 61(5):2015-23. PubMed ID: 7683001
[TBL] [Abstract][Full Text] [Related]
4. Natural and synthetic LPS and lipid a analogs or partial structures that antagonize or induce tolerance to LPS.
Qureshi N; Jarvis B; Takayama K; Sattar N; Hofman J; Stütz P
Prog Clin Biol Res; 1998; 397():289-300. PubMed ID: 9575570
[No Abstract] [Full Text] [Related]
5. Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A.
Henricson BE; Perera PY; Qureshi N; Takayama K; Vogel SN
Infect Immun; 1992 Oct; 60(10):4285-90. PubMed ID: 1398939
[TBL] [Abstract][Full Text] [Related]
6. Tolerance-inducing mechanisms to lethal toxicity of LPS by synthetic lipid A analogs.
Matsuura M; Ito Y; Kiso M; Hasegawa A; Homma JY
Jpn J Med Sci Biol; 1990 Dec; 43(6):274-5. PubMed ID: 2101159
[No Abstract] [Full Text] [Related]
7. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action.
Freudenberg MA; Galanos C
Int Rev Immunol; 1990; 6(4):207-21. PubMed ID: 2102904
[TBL] [Abstract][Full Text] [Related]
8. Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity.
Satoh M; Tsurumaki K; Kagehara H; Yamazaki M
Cancer Immunol Immunother; 2002 Feb; 50(12):653-62. PubMed ID: 11862417
[TBL] [Abstract][Full Text] [Related]
9. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
Sato K; Yoo YC; Fukushima A; Saiki I; Takahashi TA; Fujihara M; Tono-Oka S; Azuma I
Infect Immun; 1995 Aug; 63(8):2859-66. PubMed ID: 7622206
[TBL] [Abstract][Full Text] [Related]
10. Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures.
Moran AP
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):121-30. PubMed ID: 7640672
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate.
Shiozaki M; Doi H; Tanaka D; Shimozato T; Kurakata S
Bioorg Med Chem; 2006 May; 14(9):3011-6. PubMed ID: 16403638
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of 1-O-[5-(carboxy)pentanoyl]-2-deoxy-2-(2,2- difluorotetradecanamido)-3-O-[(R)-3-(tetradecanoyloxy)tetradecanoyl]-4- O- phosphono-alpha-D-glucopyranose and its analogues.
Shiozaki M; Miyazaki H; Arai M; Hiraoka T; Kurakata S; Tatsuta T; Ogawa J; Nishijima M; Akamatsu Y
Biosci Biotechnol Biochem; 1995 Mar; 59(3):501-6. PubMed ID: 7766190
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-antagonizing effects of diphosphoryl lipid A from Rhodobacter sphaeroides (Rs-DPLA).
Hofman J; Qureshi N; Takayama K; Kalin N; Manthey CL; Vogel SN; Lei MG; Morrison DC
Prog Clin Biol Res; 1994; 388():95-106. PubMed ID: 7831379
[No Abstract] [Full Text] [Related]
14. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages.
Freudenberg MA; Galanos C
Infect Immun; 1988 May; 56(5):1352-7. PubMed ID: 3356468
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide of Rhodospirillum salinarum 40: structural studies on the core and lipid A region.
Rau H; Seydel U; Freudenberg M; Weckesser J; Mayer H
Arch Microbiol; 1995 Oct; 164(4):280-9. PubMed ID: 7487334
[TBL] [Abstract][Full Text] [Related]
16. Conformation and fluidity of endotoxins as determinants of biological activity.
Brandenburg K; Schromm AB; Koch MH; Seydel U
Prog Clin Biol Res; 1995; 392():167-82. PubMed ID: 8524923
[No Abstract] [Full Text] [Related]
17. Synthesis of a 3-ether analogue of lipid A.
Shiozaki M; Kobayashi Y; Arai M; Ishida N; Hiraoka T; Nishijima M; Kuge S; Otsuka T; Akamatsu Y
Carbohydr Res; 1991 Dec; 222():69-82. PubMed ID: 1813113
[TBL] [Abstract][Full Text] [Related]
18. Anti-endotoxin activity of a novel synthetic lipid A analog.
Kawata T; Bristol JR; Rose JR; Rossignol DP; Christ WJ; Asano O; Dubuc GR; Gavin WE; Hawkins LD; Kishi Y
Prog Clin Biol Res; 1995; 392():499-509. PubMed ID: 8524958
[TBL] [Abstract][Full Text] [Related]
19. Dissection of LPS-induced signaling pathways in murine macrophages using LPS analogs, LPS mimetics, and agents unrelated to LPS.
Vogel SN; Manthey CL; Perera PY; Li ZY; Henricson BE
Prog Clin Biol Res; 1995; 392():421-31. PubMed ID: 8524949
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.
Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF
Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
